Author:
Culine S,Theodore C,De Santis M,Bui B,Demkow T,Lorenz J,Rolland F,Delgado F-M,Longerey B,James N
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Advanced Bladder Cancer Meta-Analysis Collaboration (2003) Neoadjuvant chemotherapy in invasive bladder cancer: a systemic review and meta-analysis. Cancer 361: 1927–1934
2. Albers P, Siener R, Hartlein M, Hartlein R, Fallahi M, Haeutle D, Perabo FG (2002) Gemcitabine monotherapy as second-line treatment in cisplatin-refractory transitional cell carcinoma – prognostic factors for response and improvement of quality of life. Onkologie 25: 47–52
3. Bamias A, Aravantinos G, Deliveliostis C, Bafaloukos D, Kalofonos C, Xiros N, Zervas A, Mitropoulos D, Samantas E, Pectasides D, Ppapakostas P, Gika D, Kourousis C, Koutras A, Papadimitriou C, Bamias C, Kosmidis P, Dimopoulos MA (2004) Docetaxel and cisplatin with granulocyte colong-stimulating factor (G-CSF) vs MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized phase III study from the Helenic Cooperative Oncology Group. J Clin Oncol 22: 220–228
4. Bennouna J, Fumoleau P, Armand JP, Raymond E, Campone M, Delgado FM, Puozzo C, Marty M (2003) Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumours. Ann Oncol 14: 630–637
5. Bonfil RD, Russo DM, Binda MM, Delgado FM, Vincenti M (2002) Higher antitumour activity of vinflunine than vinorelbine against an orthotopic murine model of transitional cell carcinoma of the bladder. Urol Oncol 7: 159–166
Cited by
165 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献